Table 1 The total number of TNF inhibitor reports and methotrexate reports in the combined RA cohorts separated by reported sex.

From: Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data

 

TNF inhibitors

Methotrexate

χ2 value

Male total reports n, (%)

19,848, (17.66%)

1271, (20.69%)

0.44

Female total reports n, (%)

87,161, (77.54%)

4529, (73.74%)

0.20

Unspecified total reports n, (%)

5401, (4.80%)

342, (5.57%)

0.11

Total reports n, (%)

112,410, (100%)

6142 (100%)

–

  1. The χ2 value was calculated for each row, excluding the total reports row, by comparing the percentages between each column in the row.
Back to article page